{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T17:04:51Z","timestamp":1767373491628,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s11096-020-01154-6","type":"journal-article","created":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T20:03:00Z","timestamp":1601409780000},"page":"509-517","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Colistin co-administration with other nephrotoxins: experience of teaching hospital of Latvia"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2761-7636","authenticated-orcid":false,"given":"Aleksandra","family":"Aitullina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4934-3106","authenticated-orcid":false,"given":"Santa","family":"Purvi\u0146a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0726-3375","authenticated-orcid":false,"given":"Angelika","family":"Kr\u016bmi\u0146a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,29]]},"reference":[{"key":"1154_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/978-3-030-16373-0_3","volume-title":"Polymyxin antibiotics: from laboratory bench to bedside, advances in experimental medicine and biology","author":"T Velkov","year":"2019","unstructured":"Velkov T, Thompson PE, Azad MAK, Roberts KD, Bergen PJ. History, chemistry and antibacterial spectrum. In: Li J, editor. Polymyxin antibiotics: from laboratory bench to bedside, advances in experimental medicine and biology. Cham: Springer; 2019. p. 15\u201336."},{"unstructured":"World Health Organization. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. WHO [Internet]. 2017;7. https:\/\/www.who.int\/news-room\/detail\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed. Accessed 14 June 2020.","key":"1154_CR2"},{"issue":"1","key":"1154_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.diagmicrobio.2018.11.008","volume":"94","author":"AF Oliota","year":"2019","unstructured":"Oliota AF, Penteado ST, Tonin FS, Fernandez-Llimos F, Sanches AC. Nephrotoxicity prevalence in patients treated with polymyxins: a systematic review with meta-analysis of observational studies. Diagn Microbiol Infect Dis. 2019;94(1):41\u20139.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"9","key":"1154_CR4","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1093\/cid\/cir611","volume":"53","author":"JM Pogue","year":"2011","unstructured":"Pogue JM, Lee J, Marchaim D, Yee V, Zhao JJ, Chopra T, et al. Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system. Clin Infect Dis. 2011;53(9):879\u201384.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1154_CR5","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1093\/cid\/cis909","volume":"56","author":"G Vicari","year":"2013","unstructured":"Vicari G, Bauer SR, Neuner EA, Lam SW. Association between colistin dose and microbiologic outcomes in patients with multidrug-resistant gram-negative bacteremia. Clin Infect Dis. 2013;56(3):398\u2013404.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"1154_CR6","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1093\/cid\/cis286","volume":"54","author":"L Dalfino","year":"2012","unstructured":"Dalfino L, Puntillo F, Mosca A, Monno R, Spada ML, Coppolecchia S, et al. High-dose, extended-interval colistin administration in critically ill patients: is this the right dosing strategy? A preliminary study. Clin Infect Dis. 2012;54(12):1720\u20136.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"1154_CR7","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1128\/AAC.49.8.3136-3146.2005","volume":"49","author":"SK Kasiakou","year":"2005","unstructured":"Kasiakou SK, Michalopoulos A, Soteriades ES, Samonis G, Sermaides GJ, Falagas ME. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant gram-negative bacteria in patients without cystic fibrosis. Antimicrob Agents Chemother. 2005;49(8):3136\u201346.","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"1154_CR8","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1592\/phco.31.12.1257","volume":"31","author":"NM Doshi","year":"2011","unstructured":"Doshi NM, Mount KL, Murphy CV. Nephrotoxicity associated with intravenous colistin in critically ill patients. Pharmacotherapy. 2011;31(12):1257\u201364.","journal-title":"Pharmacotherapy"},{"issue":"10","key":"1154_CR9","doi-asserted-by":"publisher","first-page":"4503","DOI":"10.1128\/AAC.01707-09","volume":"54","author":"CA DeRyke","year":"2010","unstructured":"DeRyke CA, Crawford AJ, Uddin N, Wallace MR. Colistin dosing and nephrotoxicity in a large community teaching hospital. Antimicrob Agents Chemother. 2010;54(10):4503\u20135.","journal-title":"Antimicrob Agents Chemother"},{"issue":"24","key":"1154_CR10","first-page":"1","volume":"8","author":"RL Nation","year":"2019","unstructured":"Nation RL, Maria MH, Falci DR, Zavascki AP. Polymyxin acute kidney injury: dosing and other strategies to reduce toxicity. Antibiotics. 2019;8(24):1\u201318.","journal-title":"Antibiotics"},{"issue":"5","key":"1154_CR11","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1128\/AAC.00028-12","volume":"56","author":"TP Gauthier","year":"2012","unstructured":"Gauthier TP, Wolowich WR, Reddy A, Cano E, Abbo L, Smith LB. Incidence and predictors of nephrotoxicity associated with intravenous colistin in overweight and obese patients. Antimicrob Agents Chemother. 2012;56(5):2392\u20136.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"1154_CR12","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.ijantimicag.2009.06.028","volume":"34","author":"J Kim","year":"2009","unstructured":"Kim J, Lee KH, Yoo S, Pai H. Clinical characteristics and risk factors of colistin-induced nephrotoxicity. Int J Antimicrob Agents. 2009;34(5):434\u20138.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"1154_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/phar.2209","volume":"39","author":"BT Tsuji","year":"2019","unstructured":"Tsuji BT, Pogue JM, Zavascki AP, Paul M, Daikos GL, Forrest A, et al. International consensus guidelines for the optimal use of the polymyxins: endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDS. Pharmacotherapy. 2019;39(1):10\u201339.","journal-title":"Pharmacotherapy"},{"issue":"1","key":"1154_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/kisup.2012.1","volume":"2","author":"JA Kellum","year":"2012","unstructured":"Kellum JA, Lameire N, Aspelin P, Barsoum RS, Burdmann EA, Goldstein SL, et al. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2(1):1\u2013138.","journal-title":"Kidney Int Suppl"},{"issue":"3","key":"1154_CR15","first-page":"3","volume":"12","author":"RK Shields","year":"2017","unstructured":"Shields RK, Anand R, Clarke LG, Paronish JA, Weirich M, Perone H, et al. Defining the incidence and risk factors of colistin-induced acute kidney injury by KDIGO criteria. PLoS ONE. 2017;12(3):3\u20137.","journal-title":"PLoS ONE"},{"issue":"12","key":"1154_CR16","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1093\/cid\/civ717","volume":"61","author":"L Dalfino","year":"2015","unstructured":"Dalfino L, Puntillo F, Ondok MJM, Mosca A, Monno R, Coppolecchia S, et al. Colistin-associated acute kidney injury in severely ill patients: a step toward a better renal care? A prospective cohort study. Clin Infect Dis. 2015;61(12):1771\u20137.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"1154_CR17","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.ijantimicag.2015.01.011","volume":"45","author":"KH Kwon","year":"2015","unstructured":"Kwon KH, Oh JY, Yoon YS, Jeong YJ, Kim KS, Shin SJ, et al. Colistin treatment in carbapenem-resistant Acinetobacter baumannii pneumonia patients: Incidence of nephrotoxicity and outcomes. Int J Antimicrob Agents. 2015;45(6):605\u20139.","journal-title":"Int J Antimicrob Agents"},{"key":"1154_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ijid.2020.01.022","volume":"93","author":"KL Li","year":"2020","unstructured":"Li KL, Abad CLR. The clinical profile and outcomes of adult patients given intravenous colistin for multidrug-resistant gram negative infections in a Philippine tertiary hospital. Int J Infect Dis. 2020;93:9\u201314.","journal-title":"Int J Infect Dis"},{"issue":"12","key":"1154_CR19","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1086\/599225","volume":"48","author":"JDD Hartzell","year":"2009","unstructured":"Hartzell JDD, Neff R, Ake J, Howard R, Olson S, Paolino K, et al. Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a Tertiary Care Medical Center. Clin Infect Dis. 2009;48(12):1724\u20138.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"1154_CR20","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3855\/jidc.11413","volume":"13","author":"AS Ozel","year":"2019","unstructured":"Ozel AS, Erg\u00f6n\u00fcl \u00d6, Korten V. Colistin nephrotoxicity in critically ill patients after implementation of a new dosing strategy. J Infect Dev Ctries. 2019;13(10):877\u201385.","journal-title":"J Infect Dev Ctries"},{"issue":"2","key":"1154_CR21","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s12028-007-0002-3","volume":"6","author":"M Cormio","year":"2007","unstructured":"Cormio M, Citerio G. Continuous low dose diclofenac sodium infusion to control fever in neurosurgical critical care. Neurocrit Care. 2007;6(2):82\u20139.","journal-title":"Neurocrit Care"},{"key":"1154_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-5-1","volume":"5","author":"ME Falagas","year":"2005","unstructured":"Falagas ME, Rizos M, Bliziotis IA, Rellos K, Kasiakou SK, Michalopoulos A. Toxicity after prolonged (more than four weeks) administration of intravenous colistin. BMC Infect Dis. 2005;5:1\u20138.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"1154_CR23","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jinf.2010.11.013","volume":"62","author":"P Rattanaumpawan","year":"2011","unstructured":"Rattanaumpawan P, Ungprasert P, Thamlikitkul V. Risk factors for colistin-associated nephrotoxicity. J Infect. 2011;62(2):187\u201390.","journal-title":"J Infect"},{"issue":"6","key":"1154_CR24","doi-asserted-by":"publisher","first-page":"175346661988552","DOI":"10.1177\/1753466619885529","volume":"13","author":"J Choe","year":"2019","unstructured":"Choe J, Sohn YM, Jeong SH, Park HJ, Na SJ, Huh K, et al. Inhalation with intravenous loading dose of colistin in critically ill patients with pneumonia caused by carbapenem-resistant gram-negative bacteria. Ther Adv Respir Dis. 2019;13(6):175346661988552.","journal-title":"Ther Adv Respir Dis"},{"issue":"6","key":"1154_CR25","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/aas.12897","volume":"61","author":"V Bakke","year":"2017","unstructured":"Bakke V, Sporsem H, Von der Lippe E, Nord\u00f8y I, Lao Y, Nyrer\u00f8d HC, et al. Vancomycin levels are frequently subtherapeutic in critically ill patients: a prospective observational study. Acta Anaesthesiol Scand. 2017;61(6):627\u201335.","journal-title":"Acta Anaesthesiol Scand"},{"key":"1154_CR26","first-page":"1","volume":"14","author":"I Bellos","year":"2020","unstructured":"Bellos I, Pergialiotis V, Frountzas M, Kontzoglou K, Daskalakis G, Perrea DN. Efficacy and safety of colistin loading dose: a meta-analysis. J Antimicrob Chemother. 2020;14:1\u201310.","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"1154_CR27","doi-asserted-by":"publisher","first-page":"678","DOI":"10.3109\/00365548.2014.926021","volume":"46","author":"II Balkan","year":"2014","unstructured":"Balkan II, Dogan M, Durdu B, Batirel A, Hakyemez IN, Cetin B, et al. Colistin nephrotoxicity increases with age. Scand J Infect Dis. 2014;46(10):678\u201385","journal-title":"Scand J Infect Dis."},{"issue":"12","key":"1154_CR28","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1111\/j.1469-0691.2006.01559.x","volume":"12","author":"ME Falagas","year":"2006","unstructured":"Falagas ME, Rafailidis PI, Kasiakou SK, Hatzopoulou P, Michalopoulos A. Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin-meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections. Clin Microbiol Infect. 2006;12(12):1227\u201330.","journal-title":"Clin Microbiol Infect"},{"unstructured":"Anonymous. Summary of product characteristics of colistimethate sodium 1 million I.U. powder for solution for injection. 2018. https:\/\/www.medicines.org.uk\/emc\/product\/5648\/smpc. Accessed 14 June 2020.","key":"1154_CR29"},{"issue":"12","key":"1154_CR30","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.2174\/138920111798808446","volume":"12","author":"AA Udy","year":"2011","unstructured":"Udy AA, Putt MT, Boots RJ, Lipman J. ARC\u2014augmented renal clearance. Curr Pharm Biotechnol. 2011;12(12):2020\u20139.","journal-title":"Curr Pharm Biotechnol"},{"issue":"6","key":"1154_CR31","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s40520-017-0827-3","volume":"30","author":"BB Aydo\u011fan","year":"2018","unstructured":"Aydo\u011fan BB, Y\u0131ld\u0131r\u0131m F, Zerman A, G\u00f6nderen K, T\u00fcrko\u011flu M, Aygencel G. Colistin nephrotoxicity in the ICU: is it different in the geriatric patients? Aging Clin Exp Res. 2018;30(6):573\u201380.","journal-title":"Aging Clin Exp Res"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-020-01154-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-020-01154-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-020-01154-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T23:12:29Z","timestamp":1632870749000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-020-01154-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,29]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["1154"],"URL":"https:\/\/doi.org\/10.1007\/s11096-020-01154-6","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"type":"print","value":"2210-7703"},{"type":"electronic","value":"2210-7711"}],"subject":[],"published":{"date-parts":[[2020,9,29]]},"assertion":[{"value":"20 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}